|
|
| Begins |
September 15, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Contact |
800 Enterprise Road, Suite 200
Horsham, Pennsylvania
|
|
|
|
|
|
| Description |
WEBINAR HIGHLIGHTS:
•Overview of the chemistry and pharmacology requirements associated with exploratory IND.
•Tips to help you efficiently develop promising drug and biologic candidates while maintaining the safety of human subjects.
•Presentation of the necessary preclinical and clinical approaches and CMC information to be considered when planning
Exploratory studies in humans, including studies of closely-related drugs or therapeutic biological products under an Investigational New Drug (IND) application (21 CFR 312).
|
|
|
|
